{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:35:07Z","timestamp":1793378107007,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11096-020-01012-5","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T09:04:31Z","timestamp":1586250271000},"page":"358-364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association of combination opioid, benzodiazepine, and muscle relaxant usage with emergency department visits in a nationwide cohort in the United States"],"prefix":"10.1007","volume":"43","author":[{"given":"Jonathan Hirohiko","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"key":"1012_CR1","unstructured":"Abuse NI on D. Overdose death rates. 2019 [cited 2019 Sep 12]. Available from: https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates."},{"key":"1012_CR2","unstructured":"Research starters: worldwide deaths in world war II. Natl. WWII Mus. New Orleans. [cited 2019 Sep 12]. Available from: https:\/\/www.nationalww2museum.org\/students-teachers\/student-resources\/research-starters\/research-starters-worldwide-deaths-world-war."},{"key":"1012_CR3","unstructured":"Vietnam war US. Military fatal casualty statistics. Natl. Arch. 2016 [cited 2019 Sep 12]. Available from: https:\/\/www.archives.gov\/research\/military\/vietnam-war\/casualty-statistics."},{"issue":"113\u2013130","key":"1012_CR4","first-page":"e22","volume":"10","author":"R Chou","year":"2009","unstructured":"Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(113\u2013130):e22.","journal-title":"J Pain"},{"key":"1012_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.9740\/mhc.2016.05.120","volume":"6","author":"A Schmitz","year":"2016","unstructured":"Schmitz A. Benzodiazepine use, misuse, and abuse: a review. Ment Health Clin. 2016;6:120\u20136.","journal-title":"Ment Health Clin"},{"key":"1012_CR6","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","volume":"106","author":"MA Bachhuber","year":"2016","unstructured":"Bachhuber MA, Hennessy S, Cunningham CO, Starrels JL. Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996\u20132013. Am J Public Health. 2016;106:686\u20138.","journal-title":"Am J Public Health"},{"key":"1012_CR7","doi-asserted-by":"publisher","first-page":"j760","DOI":"10.1136\/bmj.j760","volume":"356","author":"EC Sun","year":"2017","unstructured":"Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ. 2017;356:j760.","journal-title":"BMJ"},{"key":"1012_CR8","doi-asserted-by":"crossref","unstructured":"CDC guideline for prescribing opioids for chronic pain-United States, 2016. MMWR Recomm Rep. 2016 [cited 2019 Sep 16];65. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/65\/rr\/rr6501e1.htm..","DOI":"10.15585\/mmwr.rr6501e1er"},{"key":"1012_CR9","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1097\/01.BRS.0000090503.38830.AD","volume":"28","author":"MW van Tulder","year":"2003","unstructured":"van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM, Cochrane Back Review Group. Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration. Spine. 2003;28:1978\u201392.","journal-title":"Spine."},{"key":"1012_CR10","unstructured":"Concerns with concurrent therapy | Express scripts. [cited 2019 Apr 17]. Available from: https:\/\/lab.express-scripts.com\/lab\/insights\/workers-compensation\/concerns-with-concurrent-therapy."},{"key":"1012_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/bcpt.12655","volume":"120","author":"JT Horsfall","year":"2017","unstructured":"Horsfall JT, Sprague JE. The pharmacology and toxicology of the \u2018holy trinity\u2019. Basic Clin Pharmacol Toxicol. 2017;120:115\u20139.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1012_CR12","unstructured":"Relationship between concomitant benzodiazepine-opioid use and adverse outcomes among US veterans.. [cited 2019 Sep 16]. Available from: https:\/\/reference.medscape.com\/medline\/abstract\/29189516."},{"key":"1012_CR13","unstructured":"Day C. Benzodiazepines in combination with opioid pain relievers or alcohol: Greater risk of more serious ED visit outcomes. CBHSQ Rep. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2013 [cited 2019 Sep 16]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK384672\/."},{"key":"1012_CR14","unstructured":"State of Missouri Department of Social Services. Authorization Form for Anti-Anxiety Benzodiazepine usage. https:\/\/dss.mo.gov\/mhd\/cs\/pharmacy\/pdf\/AntianxietyBenzodiazepines.pdf."},{"key":"1012_CR15","unstructured":"Medical expenditure panel survey home. [cited 2018 Oct 3]. Available from: https:\/\/meps.ahrq.gov\/mepsweb\/index.jsp."},{"key":"1012_CR16","unstructured":"Medical expenditure panel survey background. [cited 2019 Sep 22]. Available from: https:\/\/meps.ahrq.gov\/mepsweb\/about_meps\/survey_back.jsp."},{"key":"1012_CR17","unstructured":"Research C for DE and. New safety measures announced for opioid analgesics, prescription opioid cough products, and benzodiazepines. FDA. 2019 [cited 2019 Sep 20]; Available from: https:\/\/www.fda.gov\/drugs\/information-drug-class\/new-safety-measures-announced-opioid-analgesics-prescription-opioid-cough-products-and."},{"key":"1012_CR18","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.jpain.2012.07.007","volume":"13","author":"DC McDonald","year":"2012","unstructured":"McDonald DC, Carlson K, Izrael D. Geographic variation in opioid prescribing in the US. J Pain. 2012;13:988\u201396.","journal-title":"J Pain."},{"key":"1012_CR19","unstructured":"Controlled substance utilization review and evaluation system. State Calif.-Dep. Justice-Off. Atty. Gen. 2016 [cited 2019 Sep 18]. Available from: https:\/\/oag.ca.gov\/cures."},{"key":"1012_CR20","doi-asserted-by":"crossref","unstructured":"Munzing T. Physician guide to appropriate opioid prescribing for noncancer pain. Perm J. 2017 [cited 2019 Sep 18];21. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5424587\/.","DOI":"10.7812\/TPP\/16-169"},{"key":"1012_CR21","unstructured":"2017pdmpannualreport.pdf. [cited 2019 Sep 19]. Available from: https:\/\/www.floridahealth.gov\/statistics-and-data\/e-forcse\/funding\/2017pdmpannualreport.pdf."},{"key":"1012_CR22","unstructured":"Illinois-opioid-action-plan-Sept-6-2017-FINAL.pdf. [cited 2019 Sep 19]. Available from: https:\/\/dph.illinois.gov\/sites\/default\/files\/publications\/Illinois-Opioid-Action-Plan-Sept-6-2017-FINAL.pdf."},{"key":"1012_CR23","unstructured":"Model-prescription-monitoring-program-PMP-Act.pdf. [cited 2019 Sep 18]. Available from: https:\/\/namsdl.org\/wp-content\/uploads\/Model-Prescription-Monitoring-Program-PMP-Act.pdf."},{"key":"1012_CR24","unstructured":"United States Department of Health and Human Services. Center for Medicaid and CHIP Services Informational Bulletin. Best Practices for Addressing Opioid Overdoses, Misuse, and Addiction. https:\/\/www.medicaid.gov\/sites\/default\/files\/Federal-Policy-Guidance\/Downloads\/cib-02-02-16.pdf."},{"key":"1012_CR25","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s11606-018-4604-6","volume":"33","author":"BM Theriault","year":"2018","unstructured":"Theriault BM, Burger CF, Schlesinger JJ. EMR implementation of default opioid prescription quantities. J Gen Intern Med. 2018;33:1827.","journal-title":"J Gen Intern Med"},{"key":"1012_CR26","unstructured":"Malte CA, Berger D, Saxon AJ, Hagedorn HJ, Achtmeyer CE, Mariano AJ, et al. Electronic medical record alert associated with reduced opioid and benzodiazepine coprescribing in high-risk veteran patients. 2018 [cited 2019 Sep 19]. Available from: https:\/\/www.ingentaconnect.com\/content\/wk\/mcar\/2018\/00000056\/00000002\/art00010."},{"key":"1012_CR27","unstructured":"2019 Medicare advantage and part D rate announcement and call letter | CMS. [cited 2019 Sep 20]. Available from: https:\/\/www.cms.gov\/newsroom\/fact-sheets\/2019-medicare-advantage-and-part-d-rate-announcement-and-call-letter."},{"key":"1012_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1177\/0046958013513678","volume":"50","author":"SB Cohen","year":"2013","unstructured":"Cohen SB, Cohen JW. The capacity of the medical expenditure panel survey to inform the affordable care act. Inq J Health Care Organ Provis Financing. 2013;50:124\u201334.","journal-title":"Inq J Health Care Organ Provis Financing"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01012-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-020-01012-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01012-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T17:17:30Z","timestamp":1619543850000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-020-01012-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1012"],"URL":"https:\/\/doi.org\/10.1007\/s11096-020-01012-5","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,7]]},"assertion":[{"value":"1 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}